ABOUT US
Who are we?
ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
The agency in brief
A central role in infectious diseases research for over 35 years. Supporting research to prevent, understand and treat emerging infectious diseases.
The ANRS Emerging Infectious diseases (ANRS MIE) was created in 2021 by the merger of two entities: the national AIDS research agency (ANRS) and the Inserm Research and Action Targeting Emerging Infectious Diseases (REACting) consortium. It is the result of a natural and necessary evolution of the historical ANRS, an institution that has contributed to major advances in the fight against HIV/AIDS and viral hepatitis.
Mission and strategy
Supporting research to prevent, understand and treat infectious diseases.
ANRS (MIE) Emerging infectious diseases operates at the heart of research and public health to prevent, understand, and treat infectious diseases, and to respond to epidemic threats.
Leading, funding and structuring research
ANRS MIE implements three majors levels of action : leading, funding and structuring research.
Organisation and governance
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Scientific commitments and values
Supporting the involvement of patient associations, mentoring the new generation of scientists, promoting quality and ethical research practices, and committing to open science.
Emergence programme
In the event of an emerging or re-emerging epidemic in France or worldwide, our agency can activate a facilitation and watch procedure for a rapid response to health crises.
Find more information here: https://anrs.fr/